Briacell Therapeutics Corp (BCTX) - News Archive

Showing 4 of 4 results.

BriaCell Takes Bold Steps Forward with 15:1 Share Consolidation and Breakthroughs in Personalized Breast Cancer Treatment,

BriaCell Therapeutics Moves Forward with 15:1 Share Consolidation Amid Promising Breast Cancer DevelopmentsBriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW; TSX: BCT), a forward-thinking clinical-stage biotechnology com...

Jan 27, 2025 • Major Pharmaceutical Preparations Industry Shares

BriaCells Bria-OTS Pioneering a Personalized Approach in Metastatic Breast Cancer Treatment,

Revolutionary Steps in Metastatic Breast Cancer Treatment: BriaCell s Innovative Bria-OTS Study Begins In a significant breakthrough for metastatic breast cancer treatment, BriaCell Therapeutics Corp. a dynamic force in...

Nov 21, 2024 • Major Pharmaceutical Preparations Industry Clinical Study

BriaCell Therapeutics Charting a Bold Course in the Battle Against Metastatic Breast Cancer in Phase 3 Trials,

Navigating New Frontiers in Metastatic Breast Cancer: BriaCell s Pioneering Phase 3 Clinical UpdateIn a transformative moment for oncological therapeutics, BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW; TSX: BCT) has...

Oct 15, 2024 • Major Pharmaceutical Preparations Industry Clinical Study

BriaCell Takes Bold Step Towards Advanced Metastatic Breast Cancer Therapy with Innov...

The fight against advanced metastatic breast cancer has taken a significant leap forward as BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT), an innovative clinical-stage biotechnology company specializing i...

May 30, 2024 • Major Pharmaceutical Preparations Industry Announcement